Valeant's Siliq Cleared, AmSpa Survey, New Skin Cancer Imaging

Name: Valeant's Siliq Cleared, AmSpa Survey, New Skin Cancer Imaging
Uploaded: 2017-02-23T10:36:00+00:00
Duration: 4 min
Description: The FDA has approved Valeant Pharmaceutical's Siliq (brodalumab) injection for subcutaneous use for patients with moderate-to-severe plaque psoriasis. The

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Update on the Safety and Efficacy of Nicotinamide for Skin Cancer Chemoprevention
Update on the Safety and Efficacy of Nicotinamide for Skin Cancer Chemoprevention
Skin Cancer & Photoprotection
Update on the Safety and Efficacy of Nicotinamide for Skin Cancer Chemoprevention
Sami Jelousi, MD; Lee Wheless, MD, PhD
Sami Jelousi, MD; Lee Wheless, MD, PhD
Going Beyond Staging for Gene Expression Profiling in Melanoma and Cutaneous Squamous Cell Carcinoma
Going Beyond Staging for Gene Expression Profiling in Melanoma and Cutaneous Squamous Cell Carcinoma
Skin Cancer & Photoprotection
Going Beyond Staging for Gene Expression Profiling in Melanoma and Cutaneous Squamous Cell Carcinoma
Umer Nadir, MD; George Jeha, MD
Umer Nadir, MD; George Jeha, MD
Comparing Sunscreen for Skin of Color: Print-Ready Charts for Download
Comparing Sunscreen for Skin of Color: Print-Ready Charts for Download
Skin Cancer & Photoprotection
Comparing Sunscreen for Skin of Color: Print-Ready Charts for Download
Jeanette Akuamoah; Vincent Doan
Jeanette Akuamoah; Vincent Doan
From Diagnosis to Prognosis: Using MyPath^® Melanoma and DecisionDx^®-Melanoma to Help Guide Patient Management Decisions
From Diagnosis to Prognosis: Using MyPath^® Melanoma and DecisionDx^®-Melanoma to Help Guide Patient Management Decisions
Skin Cancer & Photoprotection
From Diagnosis to Prognosis: Using MyPath^® Melanoma and DecisionDx^®-Melanoma to Help Guide Patient Management Decisions
Jason Rizzo, MD, PhD
Jason Rizzo, MD, PhD